BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 33055251)

  • 1. A Novel Mechanism Underlying Antiviral Activity of an Influenza Virus M2-Specific Antibody.
    Manzoor R; Eguchi N; Yoshida R; Ozaki H; Kondoh T; Okuya K; Miyamoto H; Takada A
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33055251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
    Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Analyses of the Antiviral Activities of IgG and IgA Antibodies to Influenza A Virus M2 Protein.
    Okuya K; Eguchi N; Manzoor R; Yoshida R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Miyamoto H; Ichii O; Kajihara M; Higashi H; Takada A
    Viruses; 2020 Jul; 12(7):. PubMed ID: 32698456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of an M2-specific monoclonal antibody on different strains of influenza A virus.
    Muto NA; Yoshida R; Suzuki T; Kobayashi S; Ozaki H; Fujikura D; Manzoor R; Muramatsu M; Takada A; Kimura T; Sawa H
    Jpn J Vet Res; 2012 Aug; 60(2-3):71-83. PubMed ID: 23094582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
    Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterosubtypic antiviral activity of hemagglutinin-specific antibodies induced by intranasal immunization with inactivated influenza viruses in mice.
    Muramatsu M; Yoshida R; Miyamoto H; Tomabechi D; Kajihara M; Maruyama J; Kimura T; Manzoor R; Ito K; Takada A
    PLoS One; 2013; 8(8):e71534. PubMed ID: 23977065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem Antibody.
    Prachanronarong KL; Canale AS; Liu P; Somasundaran M; Hou S; Poh YP; Han T; Zhu Q; Renzette N; Zeldovich KB; Kowalik TF; Kurt-Yilmaz N; Jensen JD; Bolon DNA; Marasco WA; Finberg RW; Schiffer CA; Wang JP
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30381484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lateral Organization of Influenza Virus Proteins in the Budozone Region of the Plasma Membrane.
    Leser GP; Lamb RA
    J Virol; 2017 May; 91(9):. PubMed ID: 28202765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MARCH8 Restricts Influenza A Virus Infectivity but Does Not Downregulate Viral Glycoprotein Expression at the Surface of Infected Cells.
    Villalón-Letelier F; Brooks AG; Londrigan SL; Reading PC
    mBio; 2021 Oct; 12(5):e0148421. PubMed ID: 34517760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HA-Dependent Tropism of H5N1 and H7N9 Influenza Viruses to Human Endothelial Cells Is Determined by Reduced Stability of the HA, Which Allows the Virus To Cope with Inefficient Endosomal Acidification and Constitutively Expressed IFITM3.
    Hensen L; Matrosovich T; Roth K; Klenk HD; Matrosovich M
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasticity of Amino Acid Residue 145 Near the Receptor Binding Site of H3 Swine Influenza A Viruses and Its Impact on Receptor Binding and Antibody Recognition.
    Santos JJS; Abente EJ; Obadan AO; Thompson AJ; Ferreri L; Geiger G; Gonzalez-Reiche AS; Lewis NS; Burke DF; Rajão DS; Paulson JC; Vincent AL; Perez DR
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30355680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a Biologically Contained Reporter System To Study Gain-of-Function H5N1 Influenza A Viruses with Pandemic Potential.
    Spieler EE; Moritz E; Stertz S; Hale BG
    mSphere; 2020 Aug; 5(4):. PubMed ID: 32848003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Monoclonal Antibody Derived from Transchromosomic Cattle Neutralizes Multiple H1 Clades of Influenza A Virus by Recognizing a Novel Conformational Epitope in the Hemagglutinin Head Domain.
    Gao R; Sreenivasan CC; Sheng Z; Hause BM; Zhou B; Wentworth DE; Clement T; Rausch D; Brunick C; Christopher-Hennings J; Wu H; Bausch CL; Sullivan EJ; Hoppe AD; Huber VC; Wang D; Li F
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32847862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design of a deuterium-containing M2-S31N channel blocker UAWJ280 with
    Cáceres CJ; Hu Y; Cárdenas-García S; Wu X; Tan H; Carnaccini S; Gay LC; Geiger G; Ma C; Zhang QY; Rajao D; Perez DR; Wang J
    Emerg Microbes Infect; 2021 Dec; 10(1):1832-1848. PubMed ID: 34427541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Linked Glycan Sites on the Influenza A Virus Neuraminidase Head Domain Are Required for Efficient Viral Incorporation and Replication.
    Östbye H; Gao J; Martinez MR; Wang H; de Gier JW; Daniels R
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human monoclonal ScFv that bind to different functional domains of M2 and inhibit H5N1 influenza virus replication.
    Pissawong T; Maneewatch S; Thueng-In K; Srimanote P; Dong-din-on F; Thanongsaksrikul J; Songserm T; Tongtawe P; Bangphoomi K; Chaicumpa W
    Virol J; 2013 May; 10():148. PubMed ID: 23672256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of antiviral activity between IgA and IgG specific to influenza virus hemagglutinin: increased potential of IgA for heterosubtypic immunity.
    Muramatsu M; Yoshida R; Yokoyama A; Miyamoto H; Kajihara M; Maruyama J; Nao N; Manzoor R; Takada A
    PLoS One; 2014; 9(1):e85582. PubMed ID: 24465606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody against the universal M2 epitope of influenza A virus.
    Feng M; Yuan Z; Xia W; Huang X; Wang X; Yan Y; Liao M; Zhou J
    Appl Microbiol Biotechnol; 2018 Jul; 102(13):5645-5656. PubMed ID: 29736821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Defect in Influenza A Virus Particle Assembly Specific to Primary Human Macrophages.
    Bedi S; Noda T; Kawaoka Y; Ono A
    mBio; 2018 Oct; 9(5):. PubMed ID: 30352935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two Escape Mechanisms of Influenza A Virus to a Broadly Neutralizing Stalk-Binding Antibody.
    Chai N; Swem LR; Reichelt M; Chen-Harris H; Luis E; Park S; Fouts A; Lupardus P; Wu TD; Li O; McBride J; Lawrence M; Xu M; Tan MW
    PLoS Pathog; 2016 Jun; 12(6):e1005702. PubMed ID: 27351973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.